UAML
US Asset Management LLC Portfolio holdings
AUM
$115M
This Quarter Return
-3.28%
1 Year Return
+23.63%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$105M
AUM Growth
+$105M
(-6%)
Cap. Flow
-$377K
Cap. Flow
% of AUM
-0.36%
Top 10 Holdings %
Top 10 Hldgs %
38.45%
Holding
126
New
4
Increased
4
Reduced
80
Closed
4
Top Buys
| 1 |
Corcept Therapeutics
CORT
|
$381K |
| 2 |
JPMorgan Chase
JPM
|
$372K |
| 3 |
Marsh & McLennan
MMC
|
$313K |
| 4 |
CVS Health
CVS
|
$294K |
| 5 |
Fiserv
FI
|
$277K |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$348K |
| 2 |
Cencora
COR
|
$274K |
| 3 |
Manhattan Associates
MANH
|
$261K |
| 4 |
Abbott
ABT
|
$237K |
| 5 |
US Bancorp
USB
|
$220K |
Sector Composition
| 1 | Technology | 33.03% |
| 2 | Financials | 17.42% |
| 3 | Communication Services | 11.47% |
| 4 | Healthcare | 10.94% |
| 5 | Consumer Discretionary | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Corcept Therapeutics
CORT
$7.35B
| $381K | 0.36% |
+3,338
| New | +$381K |
|
77
Public Service Enterprise Group
PEG
$41.1B
| $381K | 0.36% |
4,631
| – | – |
|
78
PNC Financial Services
PNC
$81.7B
| $381K | 0.36% |
2,167
| – | – |
|
79
Chevron
CVX
$324B
| $372K | 0.36% |
2,224
-11
| -0.5% | -$1.84K |
|
80
Becton Dickinson
BDX
$55.3B
| $369K | 0.35% |
1,612
-11
| -0.7% | -$2.52K |
|
81
T Rowe Price
TROW
$23.6B
| $363K | 0.35% |
3,948
-14
| -0.4% | -$1.29K |
|
82
Teledyne Technologies
TDY
$25.2B
| $356K | 0.34% |
716
-17
| -2% | -$8.45K |
|
83
Accenture
ACN
$162B
| $349K | 0.33% |
1,119
-607
| -35% | -$189K |
|
84
Intel
INTC
$107B
| $348K | 0.33% |
15,324
-62
| -0.4% | -$1.41K |
|
85
Thermo Fisher Scientific
TMO
$186B
| $345K | 0.33% |
694
-5
| -0.7% | -$2.49K |
|
86
Yum! Brands
YUM
$40.8B
| $339K | 0.32% |
2,152
| – | – |
|
87
Fortive
FTV
$16.2B
| $336K | 0.32% |
4,590
| – | – |
|
88
RTX Corp
RTX
$212B
| $333K | 0.32% |
2,511
-16
| -0.6% | -$2.12K |
|
89
TJX Companies
TJX
$152B
| $333K | 0.32% |
2,731
| – | – |
|
90
Allegion
ALLE
$14.6B
| $329K | 0.31% |
2,519
| – | – |
|
91
Pfizer
PFE
$141B
| $320K | 0.31% |
12,637
-46
| -0.4% | -$1.17K |
|
92
Sempra
SRE
$53.9B
| $320K | 0.31% |
4,484
| – | – |
|
93
Procter & Gamble
PG
$368B
| $318K | 0.3% |
1,866
| – | – |
|
|
94
Cencora
COR
$56.5B
| $317K | 0.3% |
1,139
-985
| -46% | -$274K |
|
95
Clorox
CLX
$14.5B
| $312K | 0.3% |
2,119
| – | – |
|
96
Target
TGT
$43.6B
| $306K | 0.29% |
2,932
-27
| -0.9% | -$2.82K |
|
97
Constellation Energy
CEG
$96.2B
| $295K | 0.28% |
1,463
| – | – |
|
|
98
CVS Health
CVS
$92.8B
| $294K | 0.28% |
+4,333
| New | +$294K |
|
99
Nike
NKE
$114B
| $292K | 0.28% |
4,599
-38
| -0.8% | -$2.41K |
|
100
Lowe's Companies
LOW
$145B
| $284K | 0.27% |
1,216
| – | – |
|